Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Takeda Pharmaceutical Co. Ltd.
DescriptionPotentiator of AMPA glutamate receptor (GRIA; GLUR)
Molecular Target AMPA glutamate receptor (GRIA) (GLUR)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard Indication Neurology (unspecified)
Indication DetailsTreat psychiatric disorders and neurological diseases
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today